ALR
Alere Inc.
NYSE
People also watch:BIOHOLXHAECFNDXCM
44.060.14 (0.32%)

After hours: 44.060.00 (0.00%) as of 4:23 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close43.92
Open43.81
Bid39.00 x 200
Ask44.13 x 1600
52wk Range31.96 - 55.99
Day's Range43.73 - 44.16
Volume490,096
Avg Vol (3m)1,050,561
As of 4:02 PM EDT. Market closed.
  • American City Business Journals2 days ago

    Massachusetts class-action lawsuit filed over Alere's blood test

    Adding to a lengthy list of problems faced by Waltham-based diagnostics firm Alere as it aims to complete its merger with Abbott came one more late last week: A new class-action lawsuit over a home blood coagulation test that was recalled over concerns of ita accuracy. The lawsuit is similar to one filed in California last month, according to John Roddy, a partner in the Boston offices of Alabama-based law firm Bailey & Glasser LLP, which filed the latest class-action lawsuit against Alere on Friday in federal court in Boston. Both address problems with the INRatio home blood test sold by Alere (ALR), used by patients who take blood thinners to determine the optimum size of dose needed for treatment.

  • TheStreet.com7 days ago

    Abbott's Alere Deal Continues To Face Uncertainty

    The medical device company has two pending acquisitions worth just under $40 billion combined.